Sign in

    William Jordan

    Research Analyst at TSA Investment

    William Jordan is a Research Analyst at TSA Investment, specializing in analyzing healthcare and biotechnology companies. He has specifically covered Orgenesis, contributing to earnings call analysis and Q&A sessions to inform investment decisions. With experience focused on fundamental research, Jordan's performance record is limited in public databases, showing involvement in at least one company coverage and participation in earnings calls. Details about previous roles, FINRA registration, or securities licenses are not currently available, but his work at TSA Investment demonstrates expertise in targeted company research within the biotech sector.

    William Jordan's questions to Orgenesis (ORGS) leadership

    William Jordan's questions to Orgenesis (ORGS) leadership • Q4 2022

    Question

    William Jordan from TSA Investment asked about the impact of the significant investment from Metalmark Capital Partners on the business, specifically concerning the deployment of new OMPULs.

    Answer

    CEO Vered Caplan stated that the capital from Metalmark is crucial as it allows Orgenesis to execute its plans, provide necessary production capacity for customers, and grow with the industry. She highlighted that the investment validates their approach and provides the flexibility to respond quickly to capacity demands, a key differentiator from centralized models that require long-term planning.

    Ask Fintool Equity Research AI